DEFA14A 1 ef20067096_defa14a.htm DEFA14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐	Definitive Proxy Statement

☒	Definitive Additional Materials

☐	Soliciting Material under §240.14a-12

Bristol-Myers Squibb Company

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	No fee required.

☐	Fee paid previously with preliminary materials.

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Your Vote Counts! BRISTOL-MYERS SQUIBB COMPANY 2026 Annual Meeting Vote by May 4, 2026 11:59 PM ET. For shares held in a Plan, vote by April 30, 2026 11:59 PM ET. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # *Please check the meeting materials for any special requirements for meeting attendance. V85740-P41480-Z91645 ROUTE 206 & PROVINCE LINE ROAD PRINCETON, NJ 08543 You invested in BRISTOL-MYERS SQUIBB COMPANY and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 5, 2026. Get informed before you vote View the Notice of 2026 Annual Meeting, Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 21, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote Virtually at the Meeting* May 5, 2026 10:00 A.M. Eastern Time Virtually at: www.virtualshareholdermeeting.com/BMY2026

Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. 1. Election of Directors For Nominees: 1A) Peter J. Arduini 1B) Deepak L. Bhatt, M.D., M.P.H., M.B.A. For 1C) Christopher S. Boerner, Ph.D. For 1D) Julia A. Haller, M.D. For 1E) Manuel Hidalgo Medina, M.D., Ph.D. For 1F) Michael R. McMullen For 1G) Paula A. Price For 1H) Derica W. Rice For 1I) Theodore R. Samuels For 1J) Karen H. Vousden, Ph.D. For 1K) Phyllis R. Yale For 2. Advisory Vote to Approve the Compensation of our Named Executive Officers For 3. Vote to Approve the Company’s 2026 Stock Award and Incentive Plan For 4. Ratification of the Appointment of an Independent Registered Public Accounting Firm For 5. Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Against Voting Items Board Recommends V85741-P41480-Z91645

SEC Form DEFA14A filed by Bristol-Myers Squibb Company